Home » Topics » Regulatory

Regulatory
RSS

Health Canada approves Cingal for osteoarthritis knee pain

Nov. 5, 2015

FDA first to approve GlaxoSmithKline's Nucala

Nov. 5, 2015

FDA approves Imlygic as first oncolytic viral therapy in U.S.

Oct. 28, 2015

FDA approves Belbuca buccal film for chronic pain

Oct. 28, 2015

FDA approves Yondelis for liposarcoma and leiomyosarcoma

Oct. 26, 2015

FDA approves Merrimack's liposomal irinotecan for pancreatic cancer

Oct. 23, 2015

FDA approves Veltassa for hyperkalemia

Oct. 22, 2015

FDA approves Coagadex for hereditary factor X deficiency

Oct. 21, 2015

FDA approves Praxbind as dabigatran reversal agent

Oct. 19, 2015

FDA approves Aristada for schizophrenia

Oct. 6, 2015

Popular Stories

Today's news in brief
BioWorld
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...
RX-10616 improves radiotherapy efficacy in HNSCC
BioWorld Science
Head and neck squamous cell carcinoma (HNSCC) accounts for high number of new diagnoses each year. Current management is based on surgery followed by radiotherapy...
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...